PCOS Healthcare Trends · Evergreen explainer
Insulin resistance in PCOS/PMOS, in plain language
If the word “metabolic” in the new name PMOS feels abstract, insulin resistance is a large part of what it points to. It is also one of the most misunderstood parts of this condition: central to how clinicians explain PCOS/PMOS, and yet not one of the tests used to diagnose it. This piece separates the mechanism from the screening — what insulin does, what changes when cells respond less well to it, and what follow-up the international guideline actually recommends.
First, what insulin does on a normal day
Insulin is a hormone made by the pancreas. After you eat, sugar (glucose) from food enters the blood. Insulin is the signal that helps cells take that sugar in to use or store, so blood sugar stays in a steady range. Our glossary gives the short version: insulin resistance is when the body’s cells do not respond well to insulin, so the body makes extra insulin.
What “resistance” means, step by step
- Cells respond less strongly. Muscle, liver, and fat cells hear insulin’s signal less clearly than usual.
- The pancreas compensates. It makes more insulin, and for a while that extra amount can keep blood sugar in the normal range. That is why a normal blood-sugar result does not, by itself, describe how hard the system is working to keep it normal.
- Extra insulin reaches other tissues. Clinicians and researchers describe two connected effects that matter in PCOS/PMOS: higher insulin can signal the ovaries to produce more androgens, and it can lower a liver protein (SHBG) that normally keeps some androgen inactive — so more androgen is free to act. Androgen excess is one of the three features in the diagnosis rule explained in our diagnosis explainer.
- Over time, blood sugar can rise. If compensation stops keeping up, glucose results can move into the ranges clinicians call prediabetes and then type 2 diabetes. That progression is a risk, not a certainty, and it is the reason screening — below — is built into follow-up for this condition at all.
Three things insulin resistance is not
- It is not the diagnosis. Insulin resistance, a high insulin level, blood-sugar results, and body weight are not among the 2-of-3 features used to diagnose PCOS/PMOS. A person can meet the diagnosis rule without a documented insulin problem, and insulin resistance also occurs in people who do not have this condition at all.
- It is not the same as diabetes. Insulin resistance describes how cells respond to a hormone. Prediabetes and type 2 diabetes are defined by how high blood sugar has climbed on specific tests. The three sit on related ground, but they are different labels with different test cut-offs, and one does not automatically mean another.
- It is not only about weight. Reviews report insulin resistance across body sizes in PCOS/PMOS, including in lean patients, and estimates of how common it is vary widely — roughly a third to four-fifths in different studies — because studies measure it in different ways in different populations. Treat any single percentage you see online with caution. What the guideline takes from this picture is practical: blood-sugar status should be checked regardless of BMI.
Why there is no routine “insulin resistance test” in the guideline
This surprises many patients, because fasting insulin and calculated scores such as HOMA-IR are discussed a lot online. The 2023 International Evidence-based Guideline is explicit on the point, in its own wording: insulin resistance is a key feature of the condition’s biology, but currently available insulin tests have limited clinical value and are not recommended in routine care. One reason summaries of the guideline give is standardisation — insulin assays are not standardised across laboratories the way glucose tests are, so the same sample can read differently in different places, and there is no single agreed cut-off.
That does not mean the metabolic side is ignored. It means the guideline screens the part that can be measured reliably and acted on over time: glucose status itself.
What screening usually looks like instead
As the guideline’s recommendations are summarised by its home program at Monash and in the published guideline:
- Check glucose status at diagnosis, whatever your weight, and re-check every one to three years afterwards, with the interval based on other risk factors.
- The 75-gram oral glucose tolerance test (OGTT) — a fasting blood draw, a measured glucose drink, then a follow-up draw — is named the most accurate test for glucose status in this condition.
- Fasting glucose or A1C (the test that reflects average blood sugar over about the past three months; our glossary explains HbA1c/A1C) can be used when an OGTT is not feasible, with the guideline noting their reduced accuracy in this population compared with the OGTT.
- The wider metabolic panel travels with it: the guideline also covers a fasting lipid (cholesterol) profile at diagnosis and regular blood-pressure checks — because “metabolic” in PMOS is broader than blood sugar alone.
The U.S. Centers for Disease Control and Prevention makes the same connection in plain terms on its PCOS page, noting that more than half of women with PCOS develop type 2 diabetes by age 40 in the data it cites — a statistic about a population, not a prediction about any one person, and a further reason the screening above is routine rather than optional.
Which clinician handles which part
Metabolic follow-up is shared ground, which is exactly why it can fall between chairs:
- Primary care and OB-GYN clinicians commonly order the baseline glucose, lipid, and blood-pressure checks and keep the re-screening interval.
- Endocrinologists focus on hormone and metabolism questions — for example, when glucose results are changing, or androgen and metabolic features need to be read together.
- Registered dietitians work on the food side of metabolic health — patterns, regularity, and day-to-day practicality — rather than on diagnosis.
- Reproductive endocrinologists enter mainly when fertility timing is part of the picture, where metabolic health is one of the background factors discussed.
The useful question is not which one is “the” PCOS clinician — it is who, in your own care, owns the metabolic re-check date, so it does not quietly lapse.
What this means when you are finding care
A provider page that mentions metabolic screening, glucose follow-up, or working alongside a dietitian or endocrinologist is describing the part of care the new PMOS name was chosen to surface. You can search the directory for PCOS/PMOS-focused providers, browse by state — for example, the Florida listings page — and use the plain-language glossary for terms such as insulin resistance, A1C, and metabolic syndrome before a visit.
Questions worth asking your provider
- Has my glucose status been checked since my diagnosis — and with which test?
- Would an OGTT add anything in my case compared with fasting glucose or A1C?
- When is my next metabolic re-check due, and who keeps track of that date?
- Were my lipids and blood pressure part of the same picture, or only glucose?
- If a fasting insulin or HOMA-IR result is in my chart, how do you use it — and what are its limits?
- Would a dietitian or an endocrinologist be a useful addition to my care team, given my results so far?
Sources
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, Journal of Clinical Endocrinology & Metabolism, 2023 — read the guideline (PMC)
- The guideline program’s home at Monash University — Monash Centre for Health Research and Implementation — PCOS
- U.S. Centers for Disease Control and Prevention — PCOS and diabetes — CDC — PCOS basics
- Federal overview of the condition — NICHD — PCOS topic page
Looking for care? Find a PCOS/PMOS-focused provider or browse by state.
This article is general information published by the PMOS Directory. It is not medical advice and is not a substitute for professional medical advice, diagnosis, or treatment. It does not describe what any treatment does for any person, and it is not a recommendation for or against any treatment, product, or provider. Always seek the advice of your physician or other qualified health provider with any questions about a medical condition. If this is an emergency, call 911.